C. Schwarz
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cystic Fibrosis Research Advances 52
- Tracheal and airway disorders 14
- Inhalation and Respiratory Drug Delivery 7
- Neonatal Respiratory Health Research 7
-
- Antifungal resistance and susceptibility 22
- Co-authors
- Hendrik N. Poinar (5 shared papers)Régis Debruyne (4 shared papers)Christine King (2 shared papers)Lindsay Kalan (1 shared paper)Fabrice Calmels (1 shared paper)Vanessa M. D’Costa (1 shared paper)G. Brian Golding (1 shared paper)Gerard D. Wright (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (20 papers)Mycopathologia (7 papers)Frontiers in Cellular and Infection Microbiology (3 papers)Respiratory Medicine (3 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
C. Schwarz
97 papers receiving 4.0k citations
C. Schwarz's Hit Papers
Peers
Comparison fields: 5 of 167
- Molecular Medicine 868
- Applied Microbiology and Biotechnology 211
- Pollution 890
- Infectious Diseases 662
- Ecology 668
Countries citing papers authored by C. Schwarz
This map shows the geographic impact of C. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Schwarz more than expected).
Fields of papers citing papers by C. Schwarz
This network shows the impact of papers produced by C. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Schwarz. The network helps show where C. Schwarz may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Schwarz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibiotic resistance is ancient Hit paper breakdown → | 2011 | 1856 |
| 2 | 2005 | 406 | |
| 3 | 2002 | 248 | |
| 4 | 2004 | 157 | |
| 5 | 2009 | 124 | |
| 6 | 2009 | 73 | |
| 7 | 2015 | 72 | |
| 8 | 2017 | 63 | |
| 9 | 2019 | 49 | |
| 10 | 2022 | 47 | |
| 11 | 2017 | 46 | |
| 12 | 2017 | 42 | |
| 13 | 2013 | 38 | |
| 14 | 2017 | 36 | |
| 15 | 2017 | 34 | |
| 16 | 2020 | 34 | |
| 17 | 2015 | 31 | |
| 18 | 2013 | 30 | |
| 19 | 2017 | 29 | |
| 20 | 2012 | 25 |
About C. Schwarz
C. Schwarz is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology, Nuclear and High Energy Physics and Plant Science, having authored 110 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (52 papers), Antifungal resistance and susceptibility (22 papers), Tracheal and airway disorders (14 papers), Nuclear physics research studies (13 papers), Nematode management and characterization studies (11 papers), Mycobacterium research and diagnosis (9 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Neonatal Respiratory Health Research (7 papers). The work is most often cited by research in Molecular Medicine (868 citations), Applied Microbiology and Biotechnology (211 citations), Pollution (890 citations), Infectious Diseases (662 citations) and Ecology (668 citations). C. Schwarz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Hendrik N. Poinar, Régis Debruyne, Christine King, Lindsay Kalan, Fabrice Calmels, Vanessa M. D’Costa, G. Brian Golding, Gerard D. Wright, Wilson W. L. Sung and Duane Froese. Their work appears in journals such as Journal of Cystic Fibrosis, Mycopathologia, Frontiers in Cellular and Infection Microbiology, Respiratory Medicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.